Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

NCT03737851

CompletedPhase 2

Sponsor: AbbVie

Conditions: Multiple Sclerosis (MS)

Interventions: elezanumab, placebo

Countries: United States, Canada

The purpose of this study is to evaluate the safety and efficacy of elezanumab in participants with relapsing Multiple Sclerosis (RMS).

Eligibility overview

Sex: ALL

Age: 18 Years to 65 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Participant has diagnosis of relapsing remitting multiple sclerosis (RRMS) or secondary-progressive multiple sclerosis (SPMS) with relapses within the past 24 months.
* Participant has cranial magnetic resonance imaging (MRI) demonstrating lesion(s) consistent with multiple sclerosis (MS).
* Participant has evidence of physical disability according to Expanded Disability Status Scale (EDSS) or Timed 25-Foot Walk (T25FW) or 9-Hole Peg Test.

Exclusion Criteria:

\- Participants must not have experienced or be recovering from a clinical MS relapse within 6 months of Screening.
Locations (49)
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Berkeley, California, United States
  • Carlsbad, California, United States
  • Hanford, California, United States
  • Irvine, California, United States
  • Palo Alto, California, United States
  • Sacramento, California, United States
  • San Francisco, California, United States
  • Aurora, Colorado, United States
  • Fort Collins, Colorado, United States
  • Chicago, Illinois, United States
  • Indianapolis, Indiana, United States
  • Lenexa, Kansas, United States
  • Baton Rouge, Louisiana, United States
  • New Orleans, Louisiana, United States
  • Baltimore, Maryland, United States
  • Lutherville, Maryland, United States
  • Boston, Massachusetts, United States
  • Farmington Hills, Michigan, United States
  • Owosso, Michigan, United States
  • Chaska, Minnesota, United States
  • St Louis, Missouri, United States
  • St Louis, Missouri, United States
  • Las Vegas, Nevada, United States
  • Oklahoma City, Oklahoma, United States
  • Portland, Oregon, United States
  • Philadelphia, Pennsylvania, United States
  • Franklin, Tennessee, United States
  • Franklin, Tennessee, United States
  • + 19 more on CT.gov